2022 Conferences
Home | NAACCR 2022 Forum (naaccrforum.org)
June 14-16, 2022 | Virtual format
Our fully remote experience will offer our customary high-quality educational content and member-sponsored presentations. Plenary sessions will focus on the latest advancements in oncology and cancer surveillance, and concurrent sessions will be offered to learn about innovations and efficiencies in registry operations and cutting edge research that is occurring throughout North America. We are working hard to deliver an informative and enjoyable on-line scientific FORUM at a reduced registration fee compared to our Annual Conference.
Home - The Lancet Summit: Asian Oncology/Latin American Oncology Summit
July 14-15, 2022 | Online and On-Demand Program
This renewed event aims to highlight clinical and global oncology topics relevant for both Asia and Latin America in a post-pandemic world, allowing attendees to share experiences and learnings in both settings, to foster interdisciplinary and multinational collaboration, and to help inspire ideas to restore and improve cancer care and control.
World Cancer Congress 2022: A hybrid event in Geneva | Congress
October 18-20, 2022 | In-person | Geneva, Switzerland.
The World Cancer Congress aims to strengthen the participants' action and impact on national, regional and international scales through a multidisciplinary programme that features the latest successful interventions in cancer prevention, diagnosis, treatment and care.
International Association of Cancer Registries (iacr.com.fr)
November 8-10, 2022 - IACR Virtual Scientific Conference
Conference Topics
Cancer staging
Children, adolescents, young adults’ cancer surveillance and follow-up
Collaboration, innovation and training in registry practice
Covid-19 pandemic and its impact on registries, health services, and outcomes
Registries, research and health policy
The deadline for abstracts submission is on the 31st of May 2022.
------------------------------
Fernanda Silva Michels
[CompanyName]
------------------------------